T pates in many of the interactions between platelets and their environment.' The glycoprotein IIb-IIIa (GPIIbIIIa) complex is the most abundant platelet integriq2 and mediates platelet interactions with a variety of adhesive proteins including fibrinogen, von Willebrand factor, fibronectin, and vitronectin, both in solution and at surfaces. In addition to its role in supporting the association between circulating platelets and the initial-platelet monolayer deposited on vascular subendothelium during hemostasis, GPIIb-IIIa is of primary importance in directly mediating platelet adhesion to artificial surfaces coated with fibrinogen. 34 The GPIIb-IIIa complex recognizes at least two regions (residues 95 to 97 and residues 572 to 574) in the CY chain of fibrinogen,'.' as well as the carboxyterminal dodecapeptide sequence (residues 400 to 4 1 1) in the y chain.' Resting and activated platelets selectively interact with one or more of these The binding of fibrinogen to platelets in the fluid phase is associated with platelet aggregation and the stabilization of fibrinogen
The interaction of platelets with surface-adsorbed fibrinogen leads to the formation of irreversible platelet adhesion and spreading in a time-dependent manner. 6 Considerable experimental evidence suggests that inte- 
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GPllb-llla complex dissociation (pH 8.1, 60 minutes, 37°C). had no effect on GPllb or GPllla subunit recovery. Platelet activation with Zn+* also enhanced GPllb and GPllla recovery on fibrinogen-coated surfaces over that observed with unstimulated platelets, but GPllb and llla retention was EDTA sensitive. This correlated with the EDTA-reversible nature of Zn+*-activated platelet adhesion to fibrinogen-coated surfaces. The data (1) show that platelet adhesion to fibrinogen is accompanied by the induction of high-affinity interactions between GPllb-llla and immobilized fibrinogen that are EDTA-resistant and enhanced by platelet activation with some but not all agonists, and (2) implicate these interactions in stabilizing platelet contacts with fibrinogen-coated surfaces. grins are often clustered on the ventral surfaces of adherent cells in structures known as focal ~0ntacts.I~ This redistribution of receptors has been postulated to be important for efficient cell adhesion, and may contribute to more stable cell attachments. The redistribution of platelet membrane GPIIb-IIIa has also been described,14 and electron microscopic evidence shows the redistribution of surface GPIIbIIIa into clusters at or near areas of platelet-platelet contact during aggregation.15
A wide variety of cells including platelets have been shown to form focal adhesions when exposed to appropriate substrate^.'^.'^.'^ The present study was designed to examine GPIIb-IIIa interactions with immobilized fibrinogen after platelet adhesion. The data provide evidence for the induction of high-affinity ligand-receptor interactions that are enhanced after platelet stimulation with some but not all agonists in a manner that resembles fluid-phase platelet-fibrinogen interactions and appear to have direct implications for stabilizing platelet adhesion.
MATERIALS AND METHODS
Platelet preparation. Blood was collected from healthy volunteers after obtaining informed consent. Blood was anticoagulated with 3.2% sodium citrate. Platelet-rich plasma (PRP) was obtained after centrifugation (1 5 minutes, 280g) of the whole blood sample. The PRP was acidified to pH 6.5 with citric acid ( I mol/L) and centrifuged (20 minutes, 1,OOOg). The resulting platelet pellet was resuspended in 0.0 I mol/L HEPES-buffered modified Tyrode's solution (HBMT) containing no added calcium but l mmol/L MgCI,, and 2.0 mg/mL bovine serum albumin (BSA; Sigma Chemical CO, St Louis, MO). The platelet count was adjusted to 250,000/ pL with HBMT. Platelets were stimulated with 10 pM adenosine diphosphate (ADP), 0.2 p M A23 187 (Calbiochem, San Diego, CA), or 0.3 mmol/L ZnCI,. Other platelets were stimulated with 0.10 U/mL thrombin ( 5 minutes, 22°C) in the presence or absence of gly-pro-arg (0.5 mmol/L Peninsula Laboratories, Belmont, CA). Thrombin was neutralized with excess hirudin (Sigma). Additional platelets were stimulated with 0.15 mg/mL chymotrypsin (Sigma), 5 minutes 37°C. Chymotrypsin was neutralized with a IO-fold molar excess of phenylmethylsulfonyl fluoride. Platelets were subsequently centrifuged in the presence of 5 mmol/L EDTA and resuspended in HBMT.
Preparation of adhesive surfaces. Band I fibrinogen was prepared as previously described." It was applied to plastic microtiter wells (Dynatech Laboratories, Inc, Chantilly, VA) at a concentration of 30 pg/mL in 0.01 mol/L phosphate-buffered saline (PBS) pH 7.5 for I hour at 37°C. Preliminary data showed maximal platelet adhesion using wells coated with at least 10 pg/mL fibrinogen (data not shown). Nonreactive sites were blocked with BSA (0.2 mg/mL) (2 hours, 37°C). Wells were rinsed subsequently with HBMT and exposed to platelets. Control surfaces were coated with BSA.
Platelet udhesion and retention of GPllb and GPllla onfibrinogen-coated surfaces. Protein-coated microtiter wells were exposed to platelets for 30 to 90 minutes, at 22°C. Nonadherent platelets were removed by aspiration, and the wells were rinsed three times with 250 pL PBS. Platelet adhesion was quantified using a bicinchoninic acid (BCA) protein assay."
As described by Tuszynski and Murphy," this assay provides a rapid method for the determination of actual and relative numbers of adherent platelets. The number of platelets adhering to wells is proportional to the cell-derived protein determined by the BCA assay. The assay is performed by solubilizing adhering platelets with 200 pL of the BCA (4,4'-dicarboxy-2,2'-biquinoline) protein assay reagent. Samples are subsequently incubated at 60°C for 30 minutes, and absorbance read at 550 nm using a microtiter plate reader. Blank wells containing BSA or fibrinogen without platelets gave no detectable absorbance over background. BCA determinations, performed on increasing numbers of platelets in suspension that were added to fibrinogen-coated wells, served as positive controls. Platelet adhesion was fibrinogen specific with little or no cell attachment noted to wells coated with BSA. Results typically reflect platelet adhesion to immobilized fibrinogen after subtraction ofabsorbance reflecting platelet adhesion to BSA-coated wells. The typical absorbance reflecting nonspecific interactions between platelets and immobilized BSA was less than 0.028 U, representing less than 10% of the color development resulting from platelet adhesion to fibrinogen. Platelet interactions with BSA-coated surfaces were not affected by platelet stimulation.
The reversibility of platelet adhesion was assessed by incubating (45 minutes, 22°C) adherent platelets with HBMT containing 10 mmol/L EDTA, removing nonadherent platelets, and performing a BCA assay on the remaining cells. Control platelets were incubated with HBMT without EDTA. Specific GPIIb-IIIa subunit retention was examined using a modified enzyme-linked immunosorbent assay (ELISA). Adherent platelets were rinsed with HBMT, lysed in buffer composed of I% Triton X-100,0.15 mol/L NaCI, 0.01 mol/L Tris pH 7.5,0.5 mg/mL leupeptin (Sigma), 1 mmol/L CaCl,, with and without 10 mmol/L EDTA or 2 mg/mL DNAse I (Sigma). Microtiter wells were subsequently rinsed twice with the above buffer, and exposed (60 minutes, 22°C) to subunit-specific monoclonal antibodies (MoAbs) (anti-GPIIb lot 0 1, 1/500 dilution; anti-GPIIIa lot 05, 1/1,000 dilution; AMAC, Inc, Westbrook, ME). The wells were rinsed and exposed to alkaline phosphatase conjugated goat-antimouse F(ab), (1/500 dilution) (AMAC, Inc). After 60 minutes (22"C), wells were rinsed again, and p-nitrophenyl phosphate ( I mg/mL) (Sigma) in 10% diethanolamine, pH 9.8 added. Hydrolysis of the substrate by alkaline phosphatase resulted in yellow color development, measured at 405 nm using an ELISA autoreader (MR MicroElisa AutoReader; Dynatech Laboratories, Alexandria, VA). Nonspecific color development was assessed in the absence of primary antibody, or using wells exposed to platelets that were unable to adhere because of the presence of I00 pmol/L arginine-glycine-aspartic acidserine (RGDS; Peninsula Laboratories, Inc, Belmont, CA). This was typically subtracted from the optical density readings obtained with experimental samples. The specificity of GPIIb and/or GPIIIa retention on fibrinogen-coated microtiter wells was further determined by simultaneously evaluating the recovery of GPIb using an anti-GPIb MoAb (AMAC, Inc). GPIb, GPIIb, and/or GPIIIa availability on intact adherent platelets was quantified by the same assay but using buffers without Triton X-100.
Evaluation of the Triton X-100 insoluble platelet residue. After Triton X-100 lysis of adherent platelets as described above, microtiter wells were rinsed and residual material solubilized with 1% sodium dodecyl sulfate (SDS). The solubilized material was applied to 7.5% SDS-polyacrylamide gels without reduction," and gels were stained with silverZo (BioRad Laboratories, Richmond, CA).
RESULTS
The adhesion of unstimulated platelets to fibrinogencoated surfaces reached a maximum by 60 minutes, at 22°C (Fig 1) . Adhesion was accompanied by the retention of GPIIb and GPIIIa on adsorbed fibrinogen after Triton X-100 lysis of adherent platelets (Fig 2) . GPIIb-IIIa subunit recovery on surfaces that failed to support platelet adhesion, such as surfaces coated with albumin, was minimal. GPIIb and GPIIIa retention was also minimal if platelet adhesion to fibrinogen-coated surfaces was prevented by the presence of 100 pmol/L RGDS, or platelets were lysed before exposure to adsorbed fibrinogen.
The specificity of GPIIb and GPIIIa recovery with immobilized fibrinogen was supported further by experiments showing the retention of both GPIIb and GPIIIa subunits but not GPIb, another abundant platelet-membrane protein," after lysis of unstimulated adherent platelets ( Table  1) . Greater than 10% of GPIIb or GPIIIa detected on intact, adherent platelets remained associated with immobilized fibrinogen after platelet lysis compared with less than 1% of GPIb. This assay is likely to have overestimated the extent For of glycoprotein recovery after platelet lysis, as glycoprotein accessibility on intact platelets may have been limited because of platelet adhesion. Presumably, only glycoproteins on the "dorsal" surface of adherent platelets were measured, and GPIIb-IIIa ~l u s t e r i n g '~~'~ and migration to the "ventral" surface during adhesionI3 may have further decreased antigen availability.
A marked increase in GPIIb and GPIIIa retention was noted after platelet stimulation with thrombin (Table 1 ) , again without a similar increase in GPIb recovery. In contrast, pretreatment of platelets with prostaglandin E, (PGE,) decreased GPIIb and GPIIIa recovery. Differences between GPIIb and GPIIIa subunit recovery following lysis of adherent platelets before and after pretreatment with PGE, suggests that resting platelets were activated to some extent in the present study.
GPIIb and GPIIIa retention on fibrinogen-coated surfaces was accompanied by variable Triton X-100 cytoskeleton deposition. Silver-stained gels (Fig 3) showed the recovery of several cytoskeletal constituents including actin-binding protein, myosin, and actin from lysed, adherent platelets. Platelet lysis in the presence of EDTA increased the recovery of cytoskeletal proteins, particularly actin and myosin, and an unidentified, previously recognized 58,000-dalton p r~t e i n .~' .~~ To rule out the nonspecific coprecipitation of GPIIb and GPIIIa with the Triton X-100 insoluble cytoskeleton, experiments were performed in the presence of DNAse I. As reported by others,21 DNA= I caused the depolymerization ofactin filaments, and prevented the sedimentation of actin binding protein and myosin from lysed platelets. However, the presence of DNAse I had no effect on GPIIb or IIIa subunit retention on fibrinogen-coated surfaces (Fig 3) . These data suggest that recovery of GPIIb and GPIIIa after lysis of adherent platelets occurred independently of platelet-cytoskeleton deposition.
The sensitivity of GPIIb and GPIIIa recovery to divalentcation chelation was evaluated using EDTA under conditions previously described to disrupt GPIIb-IIIa complexes (pH 8. I, 60 minutes, 37°C).25 The data are summarized in Fig 3. Lysis of adherent platelets in the presence of 10 mmol/L EDTA at 37"C, pH 8.1 for 60 minutes had no effect on GPIIb or GPIIIa subunit recovery, as assessed using subunit specific MoAbs.
GPIIb and GPIIIa retention on fibrinogen-coated surfaces was modulated by platelet activation (Fig 4) . Platelet stimulation with ADP or thrombin-enhanced GPIIb-IIIa subunit retention above that noted after adhesion ofunstimulated platelets. These increases were not associated with equivalent increases in platelet adhesion. Moreover, thrombin-mediated trapping of GPIIb and GPIIIa by Triton X-100 insoluble fibrin was ruled out, as similar results were obtained with thrombin-stimulated platelets in the presence of gly-pro-arg. However, platelet stimulation with A23 187 or chymotrypsin failed to enhance GPIIb-IIIa subunit retention on immobilized fibrinogen, whereas platelet stimulation with ZnCI, increased GPlIb and GPIIIa recovery. Unstimulated or thrombin-activated (0.10 U/mL thrombin) platelets, as well as platelets pretreated (30 min. 37°C) with lOpmol/L PGE, were applied to fibrinogen-coated microtiter wells. After a 60-min adhesion (22°C). nonadherent platelets were removed and wells rinsed. Surfaceglycoprotein expression by adherent platelets was evaluated by ELSA using buffer without detergent and MoAbs recognizing the GPllb or GPllla subunits, or GPlb. Glycoprotein retention after lysis of adherent platelets was examined using the same ELISA procedure after platelet solubilization in Triton X-100 containing buffer. Data represent mean If-SD, n = 6.
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Resting platelets were applied to fibrinogen-coated microtiter wells for 60 minutes at 22°C. Nonadherent platelets were removed, and the wells washed. GPllb (A) and GPllla (B) subunits were detected after lysis of adherent platelets using a modified ELlSAand subunit-specific MoAbs. Glycoprotein recovery after platelet lysis in the presence of 10 mmol/L EDTA (pH 8.1,37"C, 60 minutes) or 2 mg/ mL DNAse I is presented relative to control buffer. Interestingly, the ZnCI,-induced increase in GPllb and GPllla recovery was markedly reduced after adherentplatelet lysis in the presence of EDTA (Table 2) , and correlated directly with increased EDTA-induced reversibility of platelet adhesion to immobilized fibrinogen.
DISCUSSION
The adhesion of cells to the extracellular matrix is a complex process that involves metabolic and cytoskeletal activities as well as cell-surface receptors for matrix macromolecules.26 The GPllb-llla complex is responsible for platelet interactions with fibrin~gen.'-'-~*~' Although unstimulated platelets recognize immobilized fibrinogen, a process thought to contribute to the thrombogenicity of artificial platelet interactions with fluid-phase fibrinogen require prior platelet activation., Conformational changes Nonadherent platelets were subsequently removed, the wells washed, and platelet deposition quantified using the BCA assay (A). Duplicate wells were exposed to Triton X-1 00 lysis buffer containing 1 mmol/L CaCI2, and GPllb (B) or GPllla (C) retention was monitored using an ELlSA procedure with subunit specific MoAbs. Values reflect specific color development indicative of glycoprotein recovery (mean f SD, n = 6). Nonspecific color development noted after platelet adhesion to control, albumin-coated surfaces was subtracted. Platelets were stimulated with 10 pmol/L ADP, 0.10 U/mL thrombin or 0 . 3 mmol/L ZnCI, before application to fibrinogen-coated microtiter wells. After 6 0 min (22"C), nonadherent platelets were removed and wells were washed. Some wells were subsequently used to quantify platelet adhesion using the BCA assay. Others were incubated (60 min. 22°C) with HBMT or HBMT containing EDTA (10 mmol/L), washed again, and the remaining platelet adhesion quantified using the BCA method. Platelet dissociation was calculated based on platelet adhesion before and after exposure to EDTA. In parallel experiments, platelets were incubated (60 min. 22°C) with fibrinogen-coated wells and adherent platelets lysed using Triton X-100 lysis buffer with and without 10 mmol/L EDTA (22°C). GPllb and GPllla retention was assessed using subunit-specific MoAbs by ELISA as described in Materials and Methods. Values represent inhibition of glycoprotein retention with calculations based on retention after platelet lysis in the presence and absence of EDTA (mean ? SD, n = 4). lecular events immediately responsible for the conversion of the GPIIb-IIIa complex from a resting to an active phenotype remain largely unknown.
.The present study shows that platelet adhesion to fibrinogen-coated surfaces is accompanied by the development of high-affinity interactions between GPIIb-IIIa and solidphase fibrinogen as reflected by GPIIb and GPIIIa recovery on fibrinogen-coated surfaces after Triton X-100 lysis of adherent platelets. GPIIb and GPIIIa recovery was deemed specific, as it was dependent on platelet adhesion, but independent of Triton x-100 insoluble cytoskeleton formation and significant GPIb retention.
CPIIb and GPIlIa retention on immobilized fibrinogen was enhanced by platelet stimulation with selected agonists before adhesion. Moreover, some inhibition was noted in the presence of PGE,. ADP and thrombin enhanced GPIlb and GPIIIa retention above that observed with unstimulated platelets, whereas A23 187 and chymotrypsin had no significant effect. The increases in GPlIb and GPIIIa recovery noted with ADP-or thrombin-stimulated platelets were in excess of predicted values based solely on observed, modest increases in platelet adhesion. Similar effects of agonists were recently described with respect to the stabilization of platelet-fibrinogen interactions in fluid-phase systems. 33 The increase in GPIlb and IIIa recovery with immobilized fibrinogen after lysis of stimulated, adherent platelets suggests that platelet activation may be a prerequisite for the formation of stable, high-affinity interactions between GPIIb-IIIa and fibrinogen. Platelet activation may have both quantitative and qualitative effects on ligand-receptor interactions by increasing the number of GPIIb-IIIa complexes capable of binding fibrinogen, and/or inducing the recognition of additional adhesive domains in immobilized fibrinogen. Indeed, the recently described6 selective recognition of fibrinogen and its plasmin degradation products by unstimulated and stimulated platelets would support the latter hypothesis.
GPIIb and GPIIIa subunit recovery after lysis of adherent platelets in the presence of EDTA (10 mmol/L EDTA, pH 8. I , 37°C) also resembled the resistance of irreversibly bound fibrinogen to EDTA treatment in fluid-phase systems." GPIIb and GPIIIa subunit recovery was largely insensitive to EDTA treatment under conditions previously described to disrupt the GPIIb-IIIa complex.25 These observations may suggest that both GPIIb and GPIIIa are involved in nondissociable, EDTA-resistant interactions with immobilized fibrinogen, or that GPIIb-GPIIIa complex formation may be stabilized after fibrinogen binding and resist dissociation by EDTA.
Platelet stimulation with ZnCI, also enhanced GPIIb-IIIa recovery on fibrinogen-coated surfaces after lysis of adherent platelets. The activation of platelets by ZnCI, is poorly understood, but may proceed via activation of protein kinase C,34 and/or conformational modification of the GPIIbIIIa complex.35 Interestingly, ZnC1,-treated platelets failed to form EDTA-resistant contacts with immobilized fibrinogen. As shown by data presented in Table 2 , this was accompanied by marked decreases in GPIIb and GPIIIa subunit recovery after adherent-platelet lysis in the presence of EDTA.
Thus, the data suggest that platelet adhesion to fibrinogen-coated surfaces is accompanied by the stabilization of GPIIb-IIIa interactions with immobilized fibrinogen as shown by the EDTA-resistant recovery ofGPIIb and GPIIIa after Triton X-100 lysis of adherent platelet. This recovery is inhibited by agents that block platelet stimulation and is modulated by agonist-induced GPIIb-IIIa activation states, similar to the development of nondissociable interactions between stimulated platelets and fluid-phase fibrinogen. The data describing interactions between Zn2+-stimulated platelets and immobilized fibrinogen further show a correlation between the EDTA-resistant recovery of both GPIIb and GPIIIa subunits on fibrinogen-coated surfaces and EDTA-resistant platelet adhesion.
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